FRESENIUS SE&CO KGAA (FSNUY)

13.47
0.10 0.71
OTC
Prev Close 13.38
Open 13.61
Day Low/High 13.46 / 13.61
52 Wk Low/High 11.00 / 14.80
Volume 5.37K
Exchange OTC
Shares Outstanding 556.23B
Market Cap 31.08B
Div & Yield N.A. (N.A)
Deutsche Bank's Depositary Receipts Virtual Investor Conference Presentations Now Available For On-Demand Viewing

Deutsche Bank's Depositary Receipts Virtual Investor Conference Presentations Now Available For On-Demand Viewing

NEW YORK, Nov. 15, 2019 /PRNewswire/ -- Deutsche Bank today announced that the presentations from the November 13 th and 14 th Depositary Receipts Virtual Investor Conference ("dbVIC") are now available for on-demand viewing.

Fresenius SE & Co. KGaA To Present At The DbVIC - Deutsche Bank ADR Virtual Investor Conference On 13 November 2019

Fresenius SE & Co. KGaA To Present At The DbVIC - Deutsche Bank ADR Virtual Investor Conference On 13 November 2019

Company invites individual and institutional investors, as well as advisors, to attend interactive, real-time virtual event

International Companies To Host Live Webcasts At Deutsche Bank's Depositary Receipts Virtual Investor Conference On November 13th And 14th, 2019

International Companies To Host Live Webcasts At Deutsche Bank's Depositary Receipts Virtual Investor Conference On November 13th And 14th, 2019

NEW YORK, Nov. 6, 2019 /PRNewswire/ -- Deutsche Bank today announced the lineup for its Depositary Receipts Virtual Investor Conference ("dbVIC") on November 13 th and 14 th, featuring live webcast presentations from international companies with American...

Drugmaker Akorn Receives FDA Warning Letter Regarding N.J. Facility

Drugmaker Akorn Receives FDA Warning Letter Regarding N.J. Facility

Akorn receives a warning letter from the U.S. Food & Drug Administration regarding an inspection of the company's facility in Somerset, New Jersey.

Akorn's Stock Crashes as Germany's Fresenius Ends Takeover Amid Data Allegations

Akorn's Stock Crashes as Germany's Fresenius Ends Takeover Amid Data Allegations

Akorn shares plummeted Monday after Germany's Fresenius Medical ditched its planned $5 billion takeover amid allegations of data misconduct at the Lake Forest, Ill.-based generic drugmaker.

Global Stocks Slip as 3% 10-Year Yields, Bad Tech News Unsettle Markets

Global Stocks Slip as 3% 10-Year Yields, Bad Tech News Unsettle Markets

The U.S. earnings seasons accelerates this week with 180 S&P 500 companies reporting, including big tech names such as Google, Facebook, Amazon and Microsoft.

Akorn Shares Crash 34% After Fresenius Warns on Takeover Amid Data Breach Probe

Akorn Shares Crash 34% After Fresenius Warns on Takeover Amid Data Breach Probe

Germany's Fresenius SE said a probe into alleged data breaches at Akorn could scupper its planned $5 billion takeover of the Lake Forest, Ill.-based generic drugmaker.

Stock Futures Improve After Fed's Powell Repeats 'Gradual' Rate Hike Aim

Stock Futures Improve After Fed's Powell Repeats 'Gradual' Rate Hike Aim

Global stocks were mixed in early Tuesday trading as investors sifted through prepared remarks ahead of the first of two appearances on Capitol Hill this week by new Fed chairman Jerome Powell.

Why Mylan, Perrigo and Endo Won't Be Playing Spoiler in Akorn-Fresenius Tie Up

Why Mylan, Perrigo and Endo Won't Be Playing Spoiler in Akorn-Fresenius Tie Up

Fresenius announced a deal to buy U.S. generic drugmaker Akorn Inc for $4.75 billion, or $34 per share.

European Stocks Edge Higher Ahead of Active U.S. Earnings Slate

European Stocks Edge Higher Ahead of Active U.S. Earnings Slate

European stocks extended gains Tuesday as global markets continued to rally in the wake of Emmanuel Macron's victory in Sunday's presidential elections in France and improving corporate earnings.

Fresenius and Merck Stocks Top DAX on Biosimilars Deal

Fresenius and Merck Stocks Top DAX on Biosimilars Deal

Fresenius announced a deal to buy U.S. generic drugmaker Akorn Inc for $4.75 billion and the biosimilars unit of German peer Merck KGaA.